Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Nov;104(3):750–754. doi: 10.1111/j.1476-5381.1991.tb12499.x

Characterization of endothelin receptors on a human neuroblastoma cell line: evidence for the ETA subtype.

L C Wilkes 1, M R Boarder 1
PMCID: PMC1908236  PMID: 1665749

Abstract

1. Specific binding sites for synthetic endothelin (ET) isoforms were studied on intact cells of the SK-N-MC cell line, derived from a human neuroblastoma. 2. [125I]-ET-1 (2.5 x 10(-11) M) specifically bound to a single class of binding sites on these cells (Hill coefficient of 1.06 +/- 0.04, n = 3) with an apparent Kd of 1.4 +/- 0.3 x 10(-9) M and a Bmax of 3.1 +/- 1.0 pmol mg-1 protein. [125I]-ET-3 (2.5 x 10(-11) M), did not specifically bind to SK-N-MC cells. 3. The binding of [125I]-ET-1 was competitively inhibited by other ET isoforms, the order of potency being ET-1 greater than sarafotoxin S6b greater than ET-3. 4. Association of 1 nM [125I]-ET-1 at 37 degrees C reached apparent equilibrium at 60-80 min, with half-maximal binding being achieved at 12 min. 5. Dissociation was measured after both 10 min and 60 min of association with 64% and 30% respectively of specifically bound [125I]-ET-1 dissociating. The actual amounts of [125I]-ET-1 dissociated were similar in both cases. 6. Incubation of [125I]-ET-3 with SK-N-MC cells at 37 degrees C for 60 min did not result in significant degradation of this peptide. However, [125I]-ET-1 was broken down by incubation with SK-N-MC cells, the pattern of degradation of dissociable [125I]-ET-1 (and that found in the supernatant) being different from that of non-dissociable [125I]-ET-1.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
750

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 1990 Dec 20;348(6303):730–732. doi: 10.1038/348730a0. [DOI] [PubMed] [Google Scholar]
  2. Auguet M., Delaflotte S., Chabrier P. E., Pirotzky E., Clostre F., Braquet P. Endothelin and Ca++ agonist Bay K 8644: different vasoconstrictive properties. Biochem Biophys Res Commun. 1988 Oct 14;156(1):186–192. doi: 10.1016/s0006-291x(88)80822-2. [DOI] [PubMed] [Google Scholar]
  3. Biedler J. L., Helson L., Spengler B. A. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 1973 Nov;33(11):2643–2652. [PubMed] [Google Scholar]
  4. Brown K. D., Littlewood C. J. Endothelin stimulates DNA synthesis in Swiss 3T3 cells. Synergy with polypeptide growth factors. Biochem J. 1989 Nov 1;263(3):977–980. doi: 10.1042/bj2630977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Crawford M. L., Hiley C. R., Young J. M. Characteristics of endothelin-1 and endothelin-3 stimulation of phosphoinositide breakdown differ between regions of guinea-pig and rat brain. Naunyn Schmiedebergs Arch Pharmacol. 1990 Mar;341(3):268–271. doi: 10.1007/BF00169742. [DOI] [PubMed] [Google Scholar]
  6. Fukuda Y., Hirata Y., Yoshimi H., Kojima T., Kobayashi Y., Yanagisawa M., Masaki T. Endothelin is a potent secretagogue for atrial natriuretic peptide in cultured rat atrial myocytes. Biochem Biophys Res Commun. 1988 Aug 30;155(1):167–172. doi: 10.1016/s0006-291x(88)81064-7. [DOI] [PubMed] [Google Scholar]
  7. Galron R., Kloog Y., Bdolah A., Sokolovsky M. Functional endothelin/sarafotoxin receptors in rat heart myocytes: structure-activity relationships and receptor subtypes. Biochem Biophys Res Commun. 1989 Sep 15;163(2):936–943. doi: 10.1016/0006-291x(89)92312-7. [DOI] [PubMed] [Google Scholar]
  8. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  9. Hiley C. R., Jones C. R., Pelton J. T., Miller R. C. Binding of [125I]-endothelin-1 to rat cerebellar homogenates and its interactions with some analogues. Br J Pharmacol. 1990 Oct;101(2):319–324. doi: 10.1111/j.1476-5381.1990.tb12708.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hirata Y., Yoshimi H., Takaichi S., Yanagisawa M., Masaki T. Binding and receptor down-regulation of a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. FEBS Lett. 1988 Oct 24;239(1):13–17. doi: 10.1016/0014-5793(88)80536-2. [DOI] [PubMed] [Google Scholar]
  11. Huang X. N., Hisayama T., Takayanagi I. Endothelin-1 induced contraction of rat aorta: contributions made by Ca2+ influx and activation of contractile apparatus associated with no change in cytoplasmic Ca2+ level. Naunyn Schmiedebergs Arch Pharmacol. 1990 Jan-Feb;341(1-2):80–87. doi: 10.1007/BF00195062. [DOI] [PubMed] [Google Scholar]
  12. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  13. Matsumoto H., Suzuki N., Onda H., Fujino M. Abundance of endothelin-3 in rat intestine, pituitary gland and brain. Biochem Biophys Res Commun. 1989 Oct 16;164(1):74–80. doi: 10.1016/0006-291x(89)91684-7. [DOI] [PubMed] [Google Scholar]
  14. Morishita R., Higaki J., Ogihara T. Endothelin stimulates aldosterone biosynthesis by dispersed rabbit adreno-capsular cells. Biochem Biophys Res Commun. 1989 Apr 28;160(2):628–632. doi: 10.1016/0006-291x(89)92479-0. [DOI] [PubMed] [Google Scholar]
  15. Rooney T. A., Nahorski S. R. Regional characterization of agonist and depolarization-induced phosphoinositide hydrolysis in rat brain. J Pharmacol Exp Ther. 1986 Dec;239(3):873–880. [PubMed] [Google Scholar]
  16. Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 1990 Dec 20;348(6303):732–735. doi: 10.1038/348732a0. [DOI] [PubMed] [Google Scholar]
  17. Secrest R. J., Cohen M. L. Endothelin: differential effects in vascular and nonvascular smooth muscle. Life Sci. 1989;45(15):1365–1372. doi: 10.1016/0024-3205(89)90023-4. [DOI] [PubMed] [Google Scholar]
  18. Shinmi O., Kimura S., Yoshizawa T., Sawamura T., Uchiyama Y., Sugita Y., Kanazawa I., Yanagisawa M., Goto K., Masaki T. Presence of endothelin-1 in porcine spinal cord: isolation and sequence determination. Biochem Biophys Res Commun. 1989 Jul 14;162(1):340–346. doi: 10.1016/0006-291x(89)92001-9. [DOI] [PubMed] [Google Scholar]
  19. Takagi M., Matsuoka H., Atarashi K., Yagi S. Endothelin: a new inhibitor of renin release. Biochem Biophys Res Commun. 1988 Dec 30;157(3):1164–1168. doi: 10.1016/s0006-291x(88)80996-3. [DOI] [PubMed] [Google Scholar]
  20. Wilkes L. C., Boarder M. R. Characterization of the endothelin binding site on bovine adrenomedullary chromaffin cells: comparison with vascular smooth muscle cells. Evidence for receptor heterogeneity. J Pharmacol Exp Ther. 1991 Feb;256(2):628–633. [PubMed] [Google Scholar]
  21. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]
  22. Yanagisawa M., Masaki T. Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci. 1989 Sep;10(9):374–378. doi: 10.1016/0165-6147(89)90011-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES